TransThera Biosciences
Nanjing
About TransThera Biosciences
TransThera Biosciences is a biotech company that focuses on the discovery and development of small-molecule new drugs. Its research and business strategies zero in clear unmet medical needs in oncology and inflammatory diseases through internal research and open innovation. The company was founded in 2016 and is headquartered in Nanjing, Jiangsu.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $147.9M
- Funding stage: IPO
- Last round: Series D (Feb 2023)
- Ticker: hkg:2617
- Website: transtherabio.comennewsview.aspx?class=179&id=26
- Phone: 025-86901057
Industries & Categories
Biotechnology, Life Science, Oncology
Social Profiles
Canonical: https://fsome.com/organization/transthera-biosciences-70378 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.